Aescap

Home
About us
Funds
Biotech
Invest
Contact
- Information meetings
Login

Fund structure

Fund structure09.17.2021

Aescap Life Sciences
Aescap Genetics
Performance
Fund structure
Fund management
Fund setup

Attend our meetings

News

Aescap’s portfolio company Albireo acquired for 84% premium + 44% via CVR January 9, 2023
Zai Lab’s share price is up 40% after positive phase 3 results in lung cancer January 5, 2023
Biotech Enters New Phase December 6, 2022

Aescap
Arent Janszoon Ernststraat 595C, 2nd floor, 1082 LD Amsterdam, Nederland
Tel. + 31 20 570 29 40 E-mail: service@aescap.com
Alle rechten voorbehouden. © 2022

Do not run any unnecessary risk. Read the Key Information Document of the Funds. This communication is neither an offer to sell nor a solicitation to invest. Past performance is not indicative of future results. The value of investments and any income generated may go down as well as up and is not guaranteed. Privium Fund Management B.V. (Privium) is authorized and regulated by the Dutch Authority for the Financial Markets (www.afm.nl) as an Alternative Investment Fund Manager (AIFM). The Funds and its manager, Privium Fund Management B.V., are held in the register of Dutch Authority for the Financial Markets. The Prospectus of the Funds and the Key Information Documents can be downloaded via the website of the Funds (www.aescap.com) and the Fund Manager (www.priviumfund.com). The performance overviews shown in this communication have been carefully composed by Privium Fund Management B.V. No rights can be derived from this communication.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.